Literature DB >> 19541600

Derivation of induced pluripotent stem cells from pig somatic cells.

Toshihiko Ezashi1, Bhanu Prakash V L Telugu, Andrei P Alexenko, Shrikesh Sachdev, Sunilima Sinha, R Michael Roberts.   

Abstract

For reasons that are unclear the production of embryonic stem cells from ungulates has proved elusive. Here, we describe induced pluripotent stem cells (iPSC) derived from porcine fetal fibroblasts by lentiviral transduction of 4 human (h) genes, hOCT4, hSOX2, hKLF4, and hc-MYC, the combination commonly used to create iPSC in mouse and human. Cells were cultured on irradiated mouse embryonic fibroblasts (MEF) and in medium supplemented with knockout serum replacement and FGF2. Compact colonies of alkaline phosphatase-positive cells emerged after approximately 22 days, providing an overall reprogramming efficiency of approximately 0.1%. The cells expressed porcine OCT4, NANOG, and SOX2 and had high telomerase activity, but also continued to express the 4 human transgenes. Unlike human ESC, the porcine iPSC (piPSC) were positive for SSEA-1, but negative for SSEA-3 and -4. Transcriptional profiling on Affymetrix (porcine) microarrays and real time RT-PCR supported the conclusion that reprogramming to pluripotency was complete. One cell line, ID6, had a normal karyotype, a cell doubling time of approximately 17 h, and has been maintained through >220 doublings. The ID6 line formed embryoid bodies, expressing genes representing all 3 germ layers when cultured under differentiating conditions, and teratomas containing tissues of ectoderm, mesoderm, and endoderm origin in nude mice. We conclude that porcine somatic cells can be reprogrammed to form piPSC. Such cell lines derived from individual animals could provide a means for testing the safety and efficacy of stem cell-derived tissue grafts when returned to the same pigs at a later age.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19541600      PMCID: PMC2698893          DOI: 10.1073/pnas.0905284106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  70 in total

1.  mTert expression correlates with telomerase activity during the differentiation of murine embryonic stem cells.

Authors:  L Armstrong; M Lako; J Lincoln; P M Cairns; N Hole
Journal:  Mech Dev       Date:  2000-10       Impact factor: 1.882

2.  Proliferation and differentiation of porcine inner cell mass and epiblast in vitro.

Authors:  F Wianny; C Perreau; M T Hochereau de Reviers
Journal:  Biol Reprod       Date:  1997-10       Impact factor: 4.285

3.  Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution.

Authors:  Nimet Maherali; Rupa Sridharan; Wei Xie; Jochen Utikal; Sarah Eminli; Katrin Arnold; Matthias Stadtfeld; Robin Yachechko; Jason Tchieu; Rudolf Jaenisch; Kathrin Plath; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2007-06-07       Impact factor: 24.633

4.  Stable genetic modification of human embryonic stem cells by lentiviral vectors.

Authors:  Michal Gropp; Pavel Itsykson; Orna Singer; Tamir Ben-Hur; Etti Reinhartz; Eithan Galun; Benjamin E Reubinoff
Journal:  Mol Ther       Date:  2003-02       Impact factor: 11.454

5.  Induced pluripotent stem cells generated without viral integration.

Authors:  Matthias Stadtfeld; Masaki Nagaya; Jochen Utikal; Gordon Weir; Konrad Hochedlinger
Journal:  Science       Date:  2008-09-25       Impact factor: 47.728

6.  Reprogramming of human somatic cells to pluripotency with defined factors.

Authors:  In-Hyun Park; Rui Zhao; Jason A West; Akiko Yabuuchi; Hongguang Huo; Tan A Ince; Paul H Lerou; M William Lensch; George Q Daley
Journal:  Nature       Date:  2007-12-23       Impact factor: 49.962

7.  Generation of human-induced pluripotent stem cells.

Authors:  In-Hyun Park; Paul H Lerou; Rui Zhao; Hongguang Huo; George Q Daley
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

8.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.

Authors:  Marius Wernig; Alexander Meissner; Ruth Foreman; Tobias Brambrink; Manching Ku; Konrad Hochedlinger; Bradley E Bernstein; Rudolf Jaenisch
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

Review 9.  Induced pluripotent stem cells: current progress and potential for regenerative medicine.

Authors:  Giovanni Amabile; Alexander Meissner
Journal:  Trends Mol Med       Date:  2009-01-21       Impact factor: 11.951

10.  Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.

Authors:  Masato Nakagawa; Michiyo Koyanagi; Koji Tanabe; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Keisuke Okita; Yuji Mochiduki; Nanako Takizawa; Shinya Yamanaka
Journal:  Nat Biotechnol       Date:  2007-11-30       Impact factor: 54.908

View more
  164 in total

1.  Evidence for premature aging due to oxidative stress in iPSCs from Cockayne syndrome.

Authors:  Luciana Nogueira de Sousa Andrade; Jason L Nathanson; Gene W Yeo; Carlos Frederico Martins Menck; Alysson Renato Muotri
Journal:  Hum Mol Genet       Date:  2012-06-01       Impact factor: 6.150

2.  Generation of pig iPS cells: a model for cell therapy.

Authors:  Núria Montserrat; Elena Garreta Bahima; Laura Batlle; Sophia Häfner; Alexandre Miguel Cavaco Rodrigues; Federico González; Juan Carlos Izpisúa Belmonte
Journal:  J Cardiovasc Transl Res       Date:  2010-11-19       Impact factor: 4.132

3.  Proliferative capacity and pluripotent characteristics of porcine adult stem cells derived from adipose tissue and bone marrow.

Authors:  Lina Tang; Yupeng Yin; Haole Zhou; Guangqi Song; Anran Fan; Bo Tang; Wei Shi; Ziyi Li
Journal:  Cell Reprogram       Date:  2012-07-09       Impact factor: 1.987

4.  Rapid conversion of human ESCs into mouse ESC-like pluripotent state by optimizing culture conditions.

Authors:  Qi Gu; Jie Hao; Xiao-yang Zhao; Wei Li; Lei Liu; Liu Wang; Zhong-hua Liu; Qi Zhou
Journal:  Protein Cell       Date:  2012-01-21       Impact factor: 14.870

5.  Generation of induced pluripotent stem cell lines from Friedreich ataxia patients.

Authors:  Jun Liu; Paul J Verma; Marguerite V Evans-Galea; Martin B Delatycki; Anna Michalska; Jessie Leung; Duncan Crombie; Joseph P Sarsero; Robert Williamson; Mirella Dottori; Alice Pébay
Journal:  Stem Cell Rev Rep       Date:  2011-09       Impact factor: 5.739

Review 6.  Transgenic pigs as models for translational biomedical research.

Authors:  Bernhard Aigner; Simone Renner; Barbara Kessler; Nikolai Klymiuk; Mayuko Kurome; Annegret Wünsch; Eckhard Wolf
Journal:  J Mol Med (Berl)       Date:  2010-03-26       Impact factor: 4.599

7.  Differentiation of induced pluripotent stem cells of swine into rod photoreceptors and their integration into the retina.

Authors:  Liang Zhou; Wei Wang; Yongqing Liu; Juan Fernandez de Castro; Toshihiko Ezashi; Bhanu Prakash V L Telugu; R Michael Roberts; Henry J Kaplan; Douglas C Dean
Journal:  Stem Cells       Date:  2011-06       Impact factor: 6.277

8.  Generation of leukemia inhibitory factor and basic fibroblast growth factor-dependent induced pluripotent stem cells from canine adult somatic cells.

Authors:  Jiesi Luo; Steven T Suhr; Eun Ah Chang; Kai Wang; Pablo J Ross; Laura L Nelson; Patrick J Venta; Jason G Knott; Jose B Cibelli
Journal:  Stem Cells Dev       Date:  2011-06-15       Impact factor: 3.272

Review 9.  Stem cell potency and the ability to contribute to chimeric organisms.

Authors:  Irina Polejaeva; Shoukhrat Mitalipov
Journal:  Reproduction       Date:  2013-03-07       Impact factor: 3.906

10.  Generation of transgene-free porcine intermediate type induced pluripotent stem cells.

Authors:  Dong Li; Jan Secher; Poul Hyttel; Marilin Ivask; Miriam Kolko; Vanessa Jane Hall; Kristine K Freude
Journal:  Cell Cycle       Date:  2018-12-03       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.